Archaeosomes and Gas Vesicles as Tools for Vaccine Development
Archaea are prokaryotic organisms that were classified as a new domain in 1990. Archaeal cellular components and metabolites have found various applications in the pharmaceutical industry. Some archaeal lipids can be used to produce archaeosomes, a new family of liposomes that exhibit high stability...
Main Authors: | Natalia Adamiak, Krzysztof T. Krawczyk, Camille Locht, Magdalena Kowalewicz-Kulbat |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.746235/full |
Similar Items
-
The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
by: Yimei Jia, et al.
Published: (2021-02-01) -
Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
by: Bassel Akache, et al.
Published: (2021-02-01) -
Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
by: Dilhan J. Perera, et al.
Published: (2020-11-01) -
Haloarchaea and the Formation of Gas Vesicles
by: Felicitas Pfeifer
Published: (2015-02-01) -
Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8+ T Cells that Protect Against Subcutaneous B16-OVA Melanoma
by: Felicity C. Stark, et al.
Published: (2016-11-01)